Profile data is unavailable for this security.
About the company
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company’s abuse-deterrent oxycodone hydrochloride extended-release formulation (Oxycodone ER) based on its proprietary nPODDDS novel Point of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules). Its product portfolio includes both new products and controlled-release generic products.
- Revenue in CAD (TTM)1.23m
- Net income in CAD-4.31m
- Incorporated2009
- Employees33.00
- LocationIntellipharmaceutics International Inc30 Worcester RdETOBICOKE M9W 5X2CanadaCAN
- Phone+1 (416) 798-3001
- Fax+1 (403) 567-0339
- Websitehttps://www.intellipharmaceutics.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genix Pharmaceuticals Corp | 3.98k | -4.00m | 1.78m | -- | -- | -- | -- | 446.41 | -0.0675 | -0.0675 | 0.00007 | -0.023 | 0.002 | 0.0104 | 0.444 | -- | -196.19 | -54.69 | -661.13 | -68.59 | 57.79 | -- | -100,442.00 | -5,345.88 | 0.0412 | -3.29 | -- | -- | -- | -50.60 | -309.27 | -- | -- | -- |
Aequus Pharmaceuticals Inc | 278.21k | -2.86m | 1.99m | 12.00 | -- | -- | -- | 7.15 | -0.0216 | -0.0216 | 0.0021 | -0.0423 | 0.2937 | 1.34 | 4.26 | -- | -302.43 | -97.96 | -- | -293.31 | 53.31 | -- | -1,029.67 | -141.53 | 0.0431 | -13.68 | 10.65 | -- | -81.53 | -28.97 | 7.64 | -- | -- | -- |
Intellipharmaceutics International Inc | 1.23m | -4.31m | 2.65m | 33.00 | -- | -- | -- | 2.16 | -0.1301 | -0.1301 | 0.0371 | -0.528 | 0.6027 | -- | 3.37 | -- | -211.39 | -132.15 | -- | -- | -88.96 | -- | -350.72 | -499.37 | -- | -19.36 | -- | -- | -- | -58.75 | 43.78 | -- | -- | -- |
Radient Technologies Inc | 3.15m | -11.30m | 2.68m | 33.00 | -- | -- | -- | 0.8498 | -0.0216 | -0.0216 | 0.006 | -0.0278 | 0.1108 | 1.56 | 6.00 | -- | -39.76 | -67.36 | -- | -118.27 | -3.91 | 1.66 | -359.00 | -534.11 | 0.0251 | -3.58 | -- | -- | 45.49 | 65.30 | 69.41 | -- | 200.33 | -- |
Manitex Capital Inc. | 0.00 | 676.04k | 2.83m | -- | 4.22 | 0.335 | 5.13 | -- | 0.0534 | 0.0534 | 0.00 | 0.6716 | 0.00 | -- | -- | -- | 7.45 | -10.84 | 8.10 | -11.51 | -- | -- | -- | -- | -- | -- | 0.0392 | -- | -- | -- | 103.54 | 17.10 | -- | -- |
Eve & Co Inc | 7.77m | -5.92m | 3.73m | -- | -- | -- | -- | 0.4796 | -0.2055 | -0.2055 | 0.2698 | 0.733 | 0.1519 | 0.7493 | 8.73 | -- | -11.58 | -- | -24.24 | -- | -3.10 | -- | -76.22 | -- | 0.062 | -5.05 | 0.4892 | -- | 2.94 | -- | -71.97 | -- | -- | -- |